Rxsight Financial Statements From 2010 to 2025
| RXST Stock | USD 31.58 0.27 0.85% |
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as , as well as many indicators such as . Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
Rxsight |
Rxsight Company Return On Equity Analysis
Rxsight's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Rxsight Return On Equity | -0.14 |
Most of Rxsight's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rxsight is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Rxsight has a Return On Equity of -0.1399. This is 99.42% lower than that of the Health Care Equipment & Supplies sector and 98.4% lower than that of the Health Care industry. The return on equity for all United States stocks is 54.87% lower than that of the firm.
Rxsight Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rxsight's current stock value. Our valuation model uses many indicators to compare Rxsight value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rxsight competition to find correlations between indicators driving Rxsight's intrinsic value. More Info.Rxsight is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Rxsight by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Rxsight Financial Statements
Rxsight shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses used in cataract surgery in the United States and internationally. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Rxsight operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.